Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $29.8400 (-1.78%) ($29.1600 - $30.3500) on Thu. Jan. 18, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.31% (three month average) | RSI | 53 | Latest Price | $29.8400(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(62%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.155% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) GDXJ(-5%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.155% (StdDev 4.31%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
Resistance Level | $30.51 | 5 Day Moving Average | $30.92(-3.49%) | 10 Day Moving Average | $31.43(-5.06%) | 20 Day Moving Average | $30.51(-2.2%) | To recent high | -13.1% | To recent low | 36.3% | Market Cap | $1.853b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |